Long-term treatment with tamoxifen activates MAP kinase and mTOR pathway and enhances interaction between growth factor receptor and ERα in breast cancer cells.

被引：0
|
作者：
Fan, P
Yue, W
Wang, J
机构：
[1] Nanjing Med Univ, Nanjing, Peoples R China
[2] Univ Virginia, Charlottesville, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：84S / 84S
页数：1
相关论文
共 50 条
  • [1] Long-term treatment with tamoxifen facilitates translocation of estrogen receptor α out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells
    Fan, Ping
    Wang, Jiping
    Santen, Richard J.
    Yue, Wei
    CANCER RESEARCH, 2007, 67 (03) : 1352 - 1360
  • [2] The effect of silencing the insulin-like growth factor receptor on tamoxifen sensitive and tamoxifen resistant breast cancer cells.
    McVittie, CJ
    Khalaf, S
    Ogunkolade, BW
    Bustin, SA
    Jenkins, PJ
    Carpenter, R
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S195 - S195
  • [3] Roles of LPA receptor-mediated signaling in tumor promotion by long-term tamoxifen treatment in breast cancer cells
    Takai, Miwa
    Yamamoto, Mao
    Yashiro, Narumi
    Ikeda, Hiroko
    Tsujiuchi, Toshifumi
    CANCER SCIENCE, 2025, 116 : 542 - 542
  • [4] Keratinocyte growth factor (KGF) regulates estrogen receptor alpha (ER-α) expression via the phosphatidylinositol 3-kinase/Akt pathway in human breast cancer cells.
    Chang, HL
    Sugimoto, Y
    Park, KY
    Ye, WP
    Wang, LS
    Huang, YW
    Su, S
    Lin, YC
    BIOLOGY OF REPRODUCTION, 2004, : 246 - 246
  • [5] The role of growth factor receptor pathways in human breast cancer cells adapted to long-term estrogen deprivation
    Sabnis, GJ
    Jelovac, D
    Long, B
    Brodie, A
    CANCER RESEARCH, 2005, 65 (09) : 3903 - 3910
  • [6] Interactions between Insulin-Like Growth Factor-I, Estrogen Receptor-α (ERα) and ERβ in Regulating Growth/Apoptosis of Human Breast Cancer Cells.
    Mejia, Sylvia M.
    Enriquez, Marlene I.
    Moody, Emily E.
    Mendoza, Rhone A.
    Thordarson, Gudmundur
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [7] Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity
    Santen, RJ
    Song, RX
    Zhang, Z
    Kumar, R
    Jeng, MH
    Masamura, A
    Lawrence, J
    Berstein, L
    Yue, W
    ENDOCRINE-RELATED CANCER, 2005, 12 : S61 - S73
  • [8] Combined treatment of breast cancer cells with epigallocatechin gallate (EGCG) and Tamoxifen delays cell-growth in long-term culture: Implications for recurrent breast cancer
    Aiyer, Harini S.
    Warri, Anni M.
    Woode, Denzel R.
    Hilakivi-Clarke, Leena
    Clarke, Robert
    CANCER RESEARCH, 2012, 72
  • [9] Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer
    Nordenskjold, Anna
    Fohlin, Helena
    Fornander, Tommy
    Lofdahl, Britta
    Skoog, Lambert
    Stal, Olle
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 160 (02) : 313 - 322
  • [10] Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer
    Anna Nordenskjöld
    Helena Fohlin
    Tommy Fornander
    Britta Löfdahl
    Lambert Skoog
    Olle Stål
    Breast Cancer Research and Treatment, 2016, 160 : 313 - 322
12345